VeriMomdihydroquercetin pentacaprylate est-il sûr pendant la grossesse ?
No harmonised CLP reproductive classification or SCCS/CIR safety assessment was found for dihydroquercetin pentacaprylate. Peer‑reviewed animal and in vitro studies on the parent compound (taxifolin/dihydroquercetin) report no evidence of intrinsic reproductive/teratogenic hazard and in some cases show protective effects against chemical‑induced reproductive damage, so there is no credible evidence to up‑rank hazard. (See CosIng listing for the INCI and PubMed studies on taxifolin.) Sources: EU Official Journal (Cosmetic ingredient listing), PubMed studies on taxifolin reproductive effects.
Related ingredients
Frequently asked questions
- dihydroquercetin pentacaprylate est-il sûr pendant la grossesse ?
- No harmonised CLP reproductive classification or SCCS/CIR safety assessment was found for dihydroquercetin pentacaprylate. Peer‑reviewed animal and in vitro studies on the parent compound (taxifolin/dihydroquercetin) report no evidence of intrinsic reproductive/teratogenic hazard and in some cases show protective effects against chemical‑induced reproductive damage, so there is no credible evidence to up‑rank hazard. (See CosIng listing for the INCI and PubMed studies on taxifolin.) Sources: EU Official Journal (Cosmetic ingredient listing), PubMed studies on taxifolin reproductive effects.
- dihydroquercetin pentacaprylate est-il sûr pendant l'allaitement ?
- No data specific to lactation or breastmilk transfer for the pentacaprylate or parent dihydroquercetin were located. Because there is no evidence of reproductive toxicity or endocrine disruption for the parent and no harmonised flags, hazard and mechanism remain 0. Exposure from topical cosmetic use was not shown to be high. No SCCS/CIR contraindication found.
- dihydroquercetin pentacaprylate est-il sûr pour la peau de bébé ?
- Hazard/mechanism: no infant‑specific reproductive or developmental hazard data were found for this derivative or for taxifolin; peer‑reviewed work shows taxifolin is not a reproductive teratogen and can be protective in rodent models, so h/m remain 0. Exposure: no dermal absorption data for the pentacaprylate were located. Per instructions, when adult topical absorption evidence is lacking but the ingredient is not absolutely non‑absorbable, increase baby exposure by +1 due to higher baby surface‑area:body‑weight and immature barrier.
- Comment VeriMom évalue-t-il dihydroquercetin pentacaprylate ?
- VeriMom évalue dihydroquercetin pentacaprylate à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à dihydroquercetin pentacaprylate pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à dihydroquercetin pentacaprylate basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.